MAX
ABVC BioPharma, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
-7.85 | 36.09 | -121.76% | -0.75 | +940.89% |
| P/S |
|
13.52 | 127.4 | -89.39% |
|
|
| P/BV |
|
9.51 | 254.48 | -96.26% |
|
|
| P/FCF |
|
-21.29 | -175.09 | -87.84% |
|
|
| Ev/Ebitda |
|
-2.09 | -27.32 | -92.36% |
|
|
| Ev/S |
|
17.8 | 535.99 | -96.68% |
|
|
| Ev/FCF |
|
-5.01 | -282.69 | -98.23% |
|
|
| E/P |
|
-0.13 | 0.022 | -691.81% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-852.26 | -366.96 | 132.25% | -1655.4 | -48.52% |
| ROE |
|
-102 | 104.24 | -197.84% |
|
|
| ROA |
|
-44.51 | -2.25 | 1876.06% |
|
|
| ROIC |
|
0 | 1.17 | -100% |
|
|
| ROS |
|
-962.15 | -291.95 | 229.57% |
|
|
| ROCE |
|
-627.65 | 3.12 | -20237.07% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.56 | 0.98 | -157.19% | -0.5 | +12.14% |
| Nеt Debt/Ebitda |
|
-0.5 | 1.06 | -147.58% |
|
|
| Debt/Ratio |
|
0.32 | 0.18 | 79.44% |
|
|
| Debt/Equity |
|
9.41 | 1.59 | 491.79% |
|
|
| Debt/Net Income |
|
-0.5 | -1.45 | -65.86% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.53 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.8 | -100% | ||
| DSI |
|
0 | 0.22 | -100% |
|
|
| Average dividend growth |
|
0 | 2.43 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.49 | -100% |
|
|
| Average percentage for payments |
|
0 | 59.01 | -100% |
|
|
| Difference from average difference in sector |
|
-0.53 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
1/10
|
5.5 | -73.42 | -107.49% | ||
| Growth impulse Ebitda in 5 years |
|
-47.04 | -97.71 | -51.86% | ||
| Growth impulse Net Income in 5 years |
|
-53.75 | -85.91 | -37.43% | ||
| Growth impulse FCF in 5 years |
|
-60.67 | -91.82 | -33.93% | ||
| Growth impulse EPS in 5 years |
|
-92.18 | -75.92 | 21.42% |
IP Score
2.24/10
